{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:36:29Z","timestamp":1784846189294,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019899","name":"National Alliance for Life and Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris-Saclay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biopha.2026.119075","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:12:38Z","timestamp":1770106358000},"page":"119075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Shifting the paradigm of PSMA delivery in prostate cancer for internal radiotherapy: An innovative ultrasound-mediated approach"],"prefix":"10.1016","volume":"196","author":[{"given":"Sophie","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Grindel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Kereselidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laur\u00e8ne","family":"Jourdain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Jego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7424-3995","authenticated-orcid":false,"given":"Soizic","family":"Martin-Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Gennisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Daugas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Novell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Truillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119075_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117829","article-title":"PSMA targeted therapy: from molecular mechanisms to clinical breakthroughs in castration-resistant prostate cancer","volume":"296","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119075_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41391-023-00725-8","article-title":"Real-world treatment patterns and overall survival among men with metastatic castration-resistant prostate cancer (mCRPC) in the US medicare population","volume":"27","author":"Freedland","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119075_bib3","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3390\/biomedicines13051132","article-title":"Current status and future perspectives of nuclear medicine in prostate cancer from imaging to therapy: a comprehensive review","volume":"13","author":"Lee","year":"2025","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.biopha.2026.119075_bib4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177\u2013PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119075_bib5","unstructured":"Advanced Prostate Cancer: AUA\/SUO Guideline - American Urological Association. \u3008https:\/\/www.auanet.org\/guidelines-and-quality\/guidelines\/advanced-prostate-cancer\u3009 (accessed 2025-07-08)."},{"issue":"5","key":"10.1016\/j.biopha.2026.119075_bib6","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","article-title":"PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0","volume":"50","author":"Fendler","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"16_","key":"10.1016\/j.biopha.2026.119075_bib7","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1200\/JCO.2024.42.16_suppl.5075","article-title":"Hematologic Toxicity in 177lu-PSMA-617 Treatment for mCRPC: Unraveling the Impact of PSMA PET Bone Tumor Volume (PSMA-bTTV)","volume":"42","author":"Ghodsi","year":"2024","journal-title":"JCO"},{"issue":"2","key":"10.1016\/j.biopha.2026.119075_bib8","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1021\/acsabm.4c01551","article-title":"The compression-dominated ultrasound response of poly(n-Butyl Cyanoacrylate) hard-shelled microbubbles induces significant sonoporation and sonopermeation effects in vitro","volume":"8","author":"Bl\u00f6ck","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"issue":"12","key":"10.1016\/j.biopha.2026.119075_bib9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/17425247.2018.1547279","article-title":"Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation","volume":"15","author":"Snipstad","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2026.119075_bib10","unstructured":"Acoustic Cluster Therapy (ACT) enhances the therapeutic efficacy of paclitaxel and Abraxane\u00ae for treatment of human prostate adenocarcinoma in mice - ScienceDirect. \u3008https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168365916303820?via%3Dihub\u3009 (accessed 2025-07-08)."},{"issue":"3","key":"10.1016\/j.biopha.2026.119075_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jconrel.2013.05.039","article-title":"Improving ultrasound gene transfection efficiency by controlling ultrasound excitation of microbubbles","volume":"170","author":"Fan","year":"2013","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.biopha.2026.119075_bib12","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119075_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ultrasmedbio.2020.09.009","article-title":"Therapeutic ultrasound parameter optimization for drug delivery applied to a murine model of hepatocellular carcinoma","volume":"47","author":"Telichko","year":"2021","journal-title":"Ultrasound Med Biol."},{"issue":"31","key":"10.1016\/j.biopha.2026.119075_bib14","doi-asserted-by":"crossref","first-page":"10173","DOI":"10.1021\/acs.langmuir.8b03779","article-title":"The role of ultrasound-driven microbubble dynamics in drug delivery: from microbubble fundamentals to clinical translation","volume":"35","author":"Roovers","year":"2019","journal-title":"Langmuir"},{"issue":"6","key":"10.1016\/j.biopha.2026.119075_bib15","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ultrasmedbio.2013.12.002","article-title":"Characterization of the dynamic activities of a population of microbubbles driven by pulsed ultrasound exposure in sonoporation","volume":"40","author":"Fan","year":"2014","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.biopha.2026.119075_bib16","article-title":"Imaging response to androgen receptor inhibition using 68Ga-PSMA-11 PET: first human experience","author":"Hope","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119075_bib17","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00259-025-07083-8","article-title":"The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer","volume":"52","author":"Laudicella","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"8","key":"10.1016\/j.biopha.2026.119075_bib18","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3390\/pharmaceutics14081642","article-title":"Ultrasonic microbubble cavitation enhanced tissue permeability and drug diffusion in solid tumor therapy","volume":"14","author":"He","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119075_bib19","article-title":"Ultrasound combined with microbubble mediated immunotherapy for tumor microenvironment","volume":"15","author":"Wu","year":"2024","journal-title":"Front. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2026.119075_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2006.02.007","article-title":"Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation","volume":"112","author":"van Wamel","year":"2006","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2026.119075_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jconrel.2019.12.045","article-title":"Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation","volume":"319","author":"Owen","year":"2020","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.biopha.2026.119075_bib22","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2967\/jnumed.118.223479","article-title":"Impact of 18F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: preclinical PET\/CT Study on Mice","volume":"60","author":"Soeda","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.biopha.2026.119075_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/00368504241274022","article-title":"Clinical course and vascular endothelial growth factor signaling system expression in maxillary angiosarcoma: a case report","volume":"107","author":"Arai","year":"2024","journal-title":"Sci. Prog."},{"issue":"21","key":"10.1016\/j.biopha.2026.119075_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70354","article-title":"Important roles of PI3K\/AKT signaling pathway and relevant inhibitors in prostate cancer progression","volume":"13","author":"Wang","year":"2024","journal-title":"Cancer Med."},{"issue":"470","key":"10.1016\/j.biopha.2026.119075_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aag3326","article-title":"PSMA Redirects Cell Survival Signaling from the MAPK to the PI3K-AKT Pathways to Promote the Progression of Prostate Cancer","volume":"10","author":"Caromile","year":"2017","journal-title":"Sci. Signal"},{"issue":"2","key":"10.1016\/j.biopha.2026.119075_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ultrasmedbio.2024.10.014","article-title":"Sonopermeation with size-sorted microbubbles synergistically increases survival and enhances tumor apoptosis with L-DOX by increasing vascular permeability and perfusion in neuroblastoma xenografts","volume":"51","author":"Sundland","year":"2025","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.biopha.2026.119075_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2016.10.007","article-title":"A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer","volume":"243","author":"Dimcevski","year":"2016","journal-title":"J. Control Release"},{"issue":"7","key":"10.1016\/j.biopha.2026.119075_bib28","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.21037\/tcr-21-372","article-title":"Comparison of tumor angiogenesis in subcutaneous and orthotopic LNCaP mouse models using contrast-enhanced ultrasound imaging","volume":"10","author":"Liu","year":"2021","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119075_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s44341-025-00017-3","article-title":"The synergistic potential of mechanotherapy and sonopermeation to enhance cancer treatment effectiveness","volume":"2","author":"Neophytou","year":"2025","journal-title":"NPJ Biol. Phys. Mech."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:47:13Z","timestamp":1781880433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226001071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"alternative-id":["S0753332226001071"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119075","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shifting the paradigm of PSMA delivery in prostate cancer for internal radiotherapy: An innovative ultrasound-mediated approach","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119075"}}